NVIDIA Bundles NIMs for GenAI Drug Target Screening

Last June, NVIDIA launched NIM—NVIDIA Inference Microservices—a simple, standardized way to add generative AI to applications. Now the company has released the NIM Agent Blueprint for generative AI-based virtual screening. In a blog post announcing the news, NVIDIA describes a NIM Agent Blueprint as integrated NIMs that build a workflow.

In this case, the NVIDIA NIM Agent Blueprint is called generative virtual screening for accelerated drug discovery, and it links together AI modules to identify and improve virtual hits in the drug discovery process in a smarter and more efficient way.

At its core are three essential AI models, all NIMs:

Today's Sponsors

Today's Sponsor